The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising development. Unlike injections, this method offers a simpler way to provide GLP-1 drugs. These https://caoimhettos875675.daneblogger.com/39674473/glp-1-patches-a-new-approach-to-blood-sugar-management